← Back to Search

Diagnostic Test

Head-Mounted Visual Field Testing Device for Glaucoma

N/A

Waitlist Available

Led By Brennan Eadie, MD, PhD

Research Sponsored by Brennan Eadie

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ability to understand and consent to the study

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 weeks

Awards & highlights

Study Summary

This trial is testing a new head-mounted device for visual field testing to see if it is as effective as the conventional visual field test.

Who is the study for?

This trial is for individuals who can consent and have had a visual field test indicating normal or varying degrees of glaucomatous damage. It excludes those with anxiety disorders, severe vertigo, certain past eye surgeries (except cataract surgery), pregnancy, seizure disorders, extreme refractive errors, inability to make informed decisions, significant eye opacity, cardiac pacemakers or similar devices.Check my eligibility

What is being tested?

The study tests a new head-mounted device for visual field testing against the standard Humphrey Visual Field Analyzer in patients with different stages of glaucoma. Each participant will use both devices over five weekly visits and complete questionnaires on comfort and satisfaction.See study design

What are the potential side effects?

Since this trial involves non-invasive testing rather than medication or surgery, side effects are minimal but may include discomfort from wearing the head-mounted device or fatigue from frequent testing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I understand the study and agree to participate.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Visual field differential light sensitivity

Secondary outcome measures

Reproducibility of sensitivity values

Trial Design

1Treatment groups

Experimental Treatment

Group I: Single ArmExperimental Treatment1 Intervention

Patients will perform visual field testing with the Humphrey Visual Field Analyzer and with the custom head-mounted device.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Brennan EadieLead Sponsor

1 Previous Clinical Trials

30 Total Patients Enrolled

1 Trials studying Glaucoma

30 Patients Enrolled for Glaucoma

Brennan Eadie, MD, PhDPrincipal InvestigatorNova Scotia Healthy Authority

1 Previous Clinical Trials

30 Total Patients Enrolled

1 Trials studying Glaucoma

30 Patients Enrolled for Glaucoma

Media Library

Visual Field Testing (Diagnostic Test) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05030714 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this experiment currently accessible to participants?

"The clinical trial in question is no longer open for recruitment, according to the data hosted on clinicaltrials.gov. Initially posted on November 1st 2021 and last edited August 31st 2021, this study has since been superseded by 206 other medical studies that are currently seeking patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluation of a Novel Head-Mounted Device for Glaucoma Testing: A Proof-of-Concept Study

Brennan Eadie 2023. "Evaluation of a Novel Head-Mounted Device for Glaucoma Testing: A Proof-of-Concept Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05030714.

All > Glaucoma